Seamus O'Hara
Chief Executive Officer at Carlow Brewing Co.
Profile
Seamus O’Hara is a Partner of Seroba Kernel Life Sciences Limited and was a co-founder of Seroba.
He has a background in R&D in the pharmaceutical industry and commercialisation of technology from Irish universities.
Since 2002 he has been an active venture investor with Seroba and sits on the Boards of portfolio companies Opsona Therapeutics, Alimentary Health and Novate Medical, and is an Observer to the Board of Labcyte, Inc. He is also a Director and co-founder of BioConnect Ireland, the leading networking association in the life science sector in Ireland.
He previously held a variety of positions in the pharmaceutical industry with AstraZeneca, GlaxoSmithKline and Eli Lily.
He also held the position of Business Development Manager with BioResearch Ireland, an Irish Government agency supporting the commercialisation of technology from Irish universities.
Mr. O'Hara received BSc (1986) and MSc (1988) from Dublin City University.
Seamus O'Hara active positions
| Companies | Position | Start |
|---|---|---|
Carlow Brewing Co.
 Carlow Brewing Co. Food DistributorsDistribution Services Carlow Brewing Co. provides alcohol beverage services. It offers pale, stout, wine and beer. The company was founded in 1996 and is headquartered in Bagenalstown, Ireland. | Chief Executive Officer | - |
Former positions of Seamus O'Hara
| Companies | Position | End |
|---|---|---|
Seroba BioVentures Ltd.
 Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Founder | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Director/Board Member | - |
PrecisionBiotics Group Ltd.
 PrecisionBiotics Group Ltd. Pharmaceuticals: GenericHealth Technology PrecisionBiotics Group Ltd. operates as a healthcare company. It focuses on isolation, characterization, clinical evaluation, and formulation of unique bacterial strain and actives for inflammatory and infectious conditions. The company was founded by Barry Kiely in 1999 and is headquartered In Cork, Ireland. | Director/Board Member | - |
Kernel Management Partners Ltd.
 Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Private Equity Investor | - |
Training of Seamus O'Hara
| University College Dublin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PrecisionBiotics Group Ltd.
PrecisionBiotics Group Ltd. Pharmaceuticals: GenericHealth Technology PrecisionBiotics Group Ltd. operates as a healthcare company. It focuses on isolation, characterization, clinical evaluation, and formulation of unique bacterial strain and actives for inflammatory and infectious conditions. The company was founded by Barry Kiely in 1999 and is headquartered In Cork, Ireland. | Health Technology |
Kernel Management Partners Ltd.
Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Finance |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Seroba BioVentures Ltd.
Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Finance |
Carlow Brewing Co.
Carlow Brewing Co. Food DistributorsDistribution Services Carlow Brewing Co. provides alcohol beverage services. It offers pale, stout, wine and beer. The company was founded in 1996 and is headquartered in Bagenalstown, Ireland. | Distribution Services |
- Stock Market
- Insiders
- Seamus O'Hara
